pimagedine has been researched along with Dementia in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodrigues, L | 1 |
| Biasibetti, R | 1 |
| Swarowsky, A | 1 |
| Leite, MC | 1 |
| Quincozes-Santos, A | 1 |
| Quilfeldt, JA | 1 |
| Achaval, M | 1 |
| Gonçalves, CA | 1 |
1 other study available for pimagedine and Dementia
| Article | Year |
|---|---|
Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine.
Topics: Analysis of Variance; Animals; Behavior, Animal; Dementia; Disease Models, Animal; Enzyme Inhibitors | 2009 |